
Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Life sciences fund investing in European and Japanese companies working on chronic health conditions

Newton BioCapital is a life sciences venture fund that operates across two regions, Europe and Japan. It describes this dual footing as what sets it apart from other funds.
The firm aims to help portfolio companies mature and grow, creating value for patients, society and investors. Its team joins company boards and helps with decisions on preclinical and clinical programmes.
Biotech and life sciences companies in Europe and Japan, particularly those addressing long-term health conditions.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Newton BioCapital is ranked on 1 TrustList ranking at #45.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Newton BioCapital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is one of 2 here listing biotech.
Of the top 56 here, 12 also cover partners and 8 also cover fintech; 23 also work in New York City and 22 also work in Silicon Valley.
Behind Mitsui Global Investment, ahead of OCBC Bank of Singapore.
As of 2026-11-02. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Newton BioCapital.
Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Investor co-investing in subscription and software-as-a-service companies alongside venture firms
Everything here links back to the same verified catalogue. Pick your next stop.